STAGE IIB BREAST CANCER
Clinical trials for STAGE IIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study tests a drug called trastuzumab deruxtecan, which delivers chemotherapy directly to cancer cells, alone or with anastrozole (a hormone blocker), for people with early-stage HER2 low, hormone receptor positive breast cancer. The goal is to see if the cancer disappears c…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 24, 2026 02:48 UTC
-
Blood test catches cancer early: new drug aims to stop spread
Disease control Recruiting nowThis Phase 3 trial tests whether elacestrant, a new hormone therapy, can prevent distant metastasis better than standard hormone therapies in 220 patients with ER+/HER2- breast cancer whose blood tests show signs of cancer DNA (ctDNA) but no visible spread. Participants are rando…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 23, 2026 12:01 UTC